ArticleBiomarker research2022

Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors.

Miguel A Villalona-Calero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.